Bath & Body Works, Inc. (BBWI) Guidance & Earnings Results

On 2026-08-26 Bath & Body Works, Inc. raised guidance: "FY26 EPS raised to $3.13-3.33 from $3.11; adj. EPS raised to $2.60-2.80 from $3.21; net sales guidance narrowed to decline 4%-2.5% from prior range; Q3 EPS $0.05-0.10; Q3 adj. EPS $0.07-0.12; FY26 free cash flow…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-08-01 · read by EquiReason

BBWIBath & Body Works, Inc.Follow BBWI — free

Specialty Retail · Consumer Cyclical

—

Price chart with a free account

Market cap: 4.2B
P/E TTM: 5.5
Dividend yield: 3.8%
52-week: —
Next earnings: 18 Nov, in 25 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
26 Aug 26	Raised	FY26 EPS raised to $3.13-3.33 from $3.11; adj. EPS raised to $2.60-2.80 from $3.21; net sales guidance narrowed to decline 4%-2.5% from prior range; Q3 EPS $0.05-0.10; Q3 adj. EPS $0.07-0.12; FY26 free cash flow ~$650M. · full year
27 May 26	Reaffirmed	Full-year 2026 net sales decline 4.5% to 2.5%; EPS $3.00-$3.25; adjusted EPS $2.40-$2.65 · full year
4 Mar 26	Lowered	FY2026 net sales down 4.5% to 2.5%; EPS $3.00-$3.25; adjusted EPS $2.40-$2.65 · full year
20 Nov 25	Lowered	FY2025 net sales guidance from 1.5%-2.7% growth to decline of low single digits; FY2025 EPS at least $2.83 vs $3.61 prior year · full year
28 Aug 25	Raised	Adjusted EPS guidance low end raised from $3.25 to $3.35 · full year

Bath & Body Works, Inc. — questions

What guidance did Bath & Body Works, Inc. give?: On 2026-08-26: "FY26 EPS raised to $3.13-3.33 from $3.11; adj. EPS raised to $2.60-2.80 from $3.21; net sales guidance narrowed to decline 4%-2.5% from prior range; Q3 EPS $0.05-0.10; Q3 adj. EPS $0.07-0.12; FY26 free cash flow ~$650M."
When does Bath & Body Works, Inc. report earnings?: Bath & Body Works, Inc.'s next earnings report is expected on 2026-11-18.

Every figure on this page comes from Bath & Body Works, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.